Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dantrolene sodium hydrate for kidney function and albuminuria in moderate to severe CKD
jRCTs061230094Recruiting
- Start
- Apr 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dantrolene in chronic kidney disease (CKD). Primary endpoints: Daily urinary volume change, Urinary sodium excretion change and 4 more. Started Apr 2024; status: recruiting.
02
Drugs
dantrolene
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCTs061230094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061230094.